CAS: Eeva™ Continued Access Study: Assessing the Usability of Eeva in a Clinical Setting

Sponsor
Progyny, Inc. (Industry)
Overall Status
Completed
CT.gov ID
NCT01617993
Collaborator
(none)
31
3
8
10.3
1.3

Study Details

Study Description

Brief Summary

User questionnaire of Eeva System usability and reports of device malfunctions.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    This study is designed to evaluate the use of Eeva by IVF laboratory staff during routine procedures. The fertilized eggs will be placed in an Eeva dish and the development of the embryos will be monitored by the Eeva system in a standard incubator. On day 3 of embryo culture, Eeva blastocyst prediction data will be printed from the system to be used to assist the embryologist in selecting the best embryo(s). The performance of the system will be summarized and the user feedback from the embryologists will be collected.

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    31 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Eeva Continued Access Study.
    Study Start Date :
    Jun 1, 2012
    Actual Primary Completion Date :
    Feb 1, 2013
    Actual Study Completion Date :
    Feb 1, 2013

    Arms and Interventions

    Arm Intervention/Treatment
    Women undergoing IVF treatment

    Women undergoing IVF treatment

    Outcome Measures

    Primary Outcome Measures

    1. User questionnaire of Eeva System usability and reports of device malfunctions. [Participants will be followed through ongoing pregnancy, at approximately 10-12 weeks gestational age.]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 40 Years
    Sexes Eligible for Study:
    Female
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Women undergoing fresh in vitro fertilization treatment using their own eggs or donor eggs

    • Subject is ≥ 18 and ≤ 40 years of age.

    • Subject has basal antral follicle count (AFC) ≥ 8 prior to stimulation cycle.

    • Fertilization using only ejaculated sperm (fresh or frozen) - no surgically retrieved sperm.

    • Subject has ≥ 5 normally fertilized eggs (2 PN)

    • Willing to have all 2PN embryos monitored by Eeva

    • Willing to comply with study protocol and procedures and able to speak English.

    • Willing to provide written informed consent.

    Exclusion Criteria:
    • Reinseminated eggs.

    • History of cancer.

    • Gestational carriers.

    • Planned preimplantation genetic diagnosis or preimplantation genetic screening.

    • Previously enrolled in this study

    • Concurrent participation in another clinical study.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Pacific Fertility Center San Francisco California United States 94133
    2 Fertility Physicians of Northern California San Jose California United States 95124
    3 Reproductive Science Center San Ramon California United States 94583

    Sponsors and Collaborators

    • Progyny, Inc.

    Investigators

    • Study Director: Shehua Shen, ELD, MD, Progyny, Inc.

    Study Documents (Full-Text)

    None provided.

    More Information

    Additional Information:

    Publications

    None provided.
    Responsible Party:
    Progyny, Inc.
    ClinicalTrials.gov Identifier:
    NCT01617993
    Other Study ID Numbers:
    • 2012-AUX-002
    First Posted:
    Jun 13, 2012
    Last Update Posted:
    Jan 13, 2014
    Last Verified:
    Jan 1, 2014

    Study Results

    No Results Posted as of Jan 13, 2014